risperidone has been researched along with topiramate in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 15 (60.00) | 29.6817 |
| 2010's | 10 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Nemeroff, CB | 1 |
| Kasper, S; Letmaier, M; Schreinzer, D; Wolf, R | 1 |
| McIntyre, RS | 1 |
| Carbray, J; Janicak, PG; Pavuluri, MN | 1 |
| Freeman, MP; Gelenberg, AJ; Gnanadesikan, M | 1 |
| Colom, F; Comes, M; Goikolea, JM; González-Pinto, A; Olivares, JM; Rodriguez, A; Sánchez-Moreno, J; Torrent, C; Vieta, E | 1 |
| Edman, A; Fhager, B; Meiri, IM; Sjögren, M | 1 |
| Bryois, Ch; Sahli, Ch | 1 |
| Bahk, WM; Choi, SK; Chung, SK; Jon, DI; Lee, JS; Pae, CU; Paik, IH; Shin, YC; Woo, JM; Yoon, BH | 1 |
| Hsiao, MC; Lin, YH; Liu, CY | 1 |
| Bourgeois, JA; Johnson, J; Quanbeck, C | 1 |
| Coffey, B; Green, WH; Ivanov, I; Klein, M | 1 |
| Brown, BD; Devine, DP; Muehlmann, AM | 1 |
| Mowla, A; Pani, A | 1 |
| Akhondzadeh, S; Ghanizadeh, A; Mohammadi, MR; Rezaei, V; Rezazadeh, SA; Sahraian, A; Tabrizi, M | 1 |
| Friedman, MJ; Mayo, L; Schnurr, PP; Watts, BV; Weeks, WB; Young-Xu, Y | 1 |
| Bonnot, O; Cabal, S; Cohen, D; Consoli, A; Tauber, M; Thuilleaux, D | 1 |
6 review(s) available for risperidone and topiramate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
An ever-increasing pharmacopoeia for the management of patients with bipolar disorder.
Topics: Acetates; Amines; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Clozapine; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Electroconvulsive Therapy; Electromagnetic Phenomena; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Lamotrigine; Lithium; Olanzapine; Pirenzepine; Risperidone; Topiramate; Treatment Outcome; Triazines; Valproic Acid | 2000 |
Alternatives to lithium and divalproex in the maintenance treatment of bipolar disorder.
Topics: Acetates; Amines; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Calcium Channel Blockers; Carbamazepine; Clozapine; Cyclohexanecarboxylic Acids; Dibenzothiazepines; Donepezil; Fatty Acids, Omega-3; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Indans; Lamotrigine; Lithium Carbonate; Olanzapine; Piperazines; Piperidines; Pirenzepine; Quetiapine Fumarate; Risperidone; Thiazoles; Topiramate; Treatment Outcome; Triazines; Valproic Acid | 2003 |
[Psychotropics and weight gain].
Topics: Adolescent; Adult; Amisulpride; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Child; Clozapine; Dibenzothiazepines; Double-Blind Method; Female; Fructose; Haloperidol; Humans; Imidazoles; Indoles; Male; Obesity; Olanzapine; Piperazines; Placebos; Psychotropic Drugs; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Socioeconomic Factors; Sulpiride; Thiazoles; Time Factors; Topiramate; Valproic Acid; Weight Gain | 2004 |
Meta-analysis of the efficacy of treatments for posttraumatic stress disorder.
Topics: Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Female; Fructose; Humans; Male; Psychotherapy; Risperidone; Stress Disorders, Post-Traumatic; Topiramate; Treatment Outcome | 2013 |
Psychotropic treatments in Prader-Willi syndrome: a critical review of published literature.
Topics: Adolescent; Child; Child, Preschool; Cystine; Fructose; Humans; Prader-Willi Syndrome; Psychotropic Drugs; Risperidone; Topiramate | 2016 |
4 trial(s) available for risperidone and topiramate
| Article | Year |
|---|---|
1-year follow-up of patients treated with risperidone and topiramate for a manic episode.
Topics: Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Fructose; Humans; Male; Middle Aged; Pilot Projects; Risperidone; Surveys and Questionnaires; Topiramate; Treatment Outcome | 2003 |
Topiramate and divalproex in combination with risperidone for acute mania: a randomized open-label study.
Topics: Acute Disease; Adolescent; Adult; Aged; Antimanic Agents; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Body Mass Index; Drug Therapy, Combination; Female; Fructose; Humans; Male; Middle Aged; Neuroprotective Agents; Psychiatric Status Rating Scales; Risperidone; Topiramate; Valproic Acid | 2005 |
Comparison of topiramate and risperidone for the treatment of behavioral disturbances of patients with Alzheimer disease: a double-blind, randomized clinical trial.
Topics: Aged; Alzheimer Disease; Anticonvulsants; Antipsychotic Agents; Behavioral Symptoms; Caregivers; Double-Blind Method; Female; Fructose; Humans; Male; Neuropsychological Tests; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Risperidone; Topiramate; Treatment Outcome | 2010 |
Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder.
Topics: Antipsychotic Agents; Autistic Disorder; Child; Child, Preschool; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Fructose; Humans; Male; Neuroprotective Agents; Neuropsychological Tests; Psychiatric Status Rating Scales; Retrospective Studies; Risperidone; Severity of Illness Index; Topiramate; Treatment Outcome | 2010 |
15 other study(ies) available for risperidone and topiramate
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Topiramate as a mood stabilizer.
Topics: Acute Disease; Adaptation, Psychological; Adult; Antimanic Agents; Bipolar Disorder; Clonazepam; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fructose; Humans; Life Change Events; Patient Readmission; Recurrence; Risperidone; Topiramate | 2001 |
Psychotropic drugs and adverse events in the treatment of bipolar disorders revisited.
Topics: Anticonvulsants; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Female; Fructose; Humans; Lamotrigine; Male; Obesity; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Risperidone; Thiazoles; Topiramate; Triazines | 2002 |
Topiramate plus risperidone for controlling weight gain and symptoms in preschool mania.
Topics: Bipolar Disorder; Child, Preschool; Drug Therapy, Combination; Female; Fructose; Humans; Risperidone; Topiramate; Weight Gain | 2002 |
Treatment of aggressive behavior in dementia with the anticonvulsant topiramate: a retrospective pilot study.
Topics: Aged; Aged, 80 and over; Aggression; Alzheimer Disease; Anticonvulsants; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fructose; Humans; Retrospective Studies; Risperidone; Topiramate; Treatment Outcome | 2003 |
Management of atypical antipsychotic-induced weight gain in schizophrenic patients with topiramate.
Topics: Adult; Anti-Obesity Agents; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Body Weight; Child, Preschool; Clozapine; Dibenzothiazepines; Female; Fructose; Humans; Male; Olanzapine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Taiwan; Topiramate; Weight Gain | 2005 |
Treatment of olfactory hallucinations with topiramate.
Topics: Adult; Antipsychotic Agents; Fructose; Hallucinations; Humans; Male; Neuroprotective Agents; Prisons; Psychotic Disorders; Risperidone; Smell; Topiramate | 2006 |
The challenges of psychopharmacological management of children with severe developmental disabilities.
Topics: Anticonvulsants; Antipsychotic Agents; Autistic Disorder; Caregivers; Child; Developmental Disabilities; Epilepsy; Female; Foster Home Care; Fructose; Humans; Impulsive Behavior; Mental Status Schedule; Psychological Tests; Risperidone; Status Epilepticus; Topiramate; Valproic Acid | 2006 |
Pemoline (2-amino-5-phenyl-1,3-oxazol-4-one)-induced self-injurious behavior: a rodent model of pharmacotherapeutic efficacy.
Topics: Animals; Antipsychotic Agents; Central Nervous System Stimulants; Disease Models, Animal; Fructose; Grooming; Male; Motor Activity; Pemoline; Rats; Rats, Long-Evans; Risperidone; Self-Injurious Behavior; Topiramate; Treatment Outcome; Valproic Acid | 2008 |